Lineage Cell Therapeutics will report earnings after the market closes. View Calendar The market is expecting a ±14.6% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±1.8%. View Expected Move (Conf Call: Nov 6 4:30 PM)
Lineage Cell Therapeutics will report earnings after the market closes. View Calendar The market is expecting a ±6.8% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±1.9%. View Expected Move (Conf Call: Aug 12 4:30 PM)
Lineage Cell Therapeutics trades 2,704 contracts. The company has the following event: Clinical Trials at the Summit 2025 between Jun 20, 2025 and Jun 21, 2025.
